找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Esophageal Cancer; Prevention, Diagnosi Nabil F. Saba,Bassel F. El-Rayes Book 2020Latest edition Springer Nature Switzerland AG 2020 Stagin

[復制鏈接]
樓主: TRACT
21#
發(fā)表于 2025-3-25 07:14:26 | 只看該作者
Radiologic Assessment of Esophageal Cancer, different conventional anatomic modalities such as esophagograms, endoscopic ultrasound, CT, and MRI are explained. In addition, the role of PET/CT, a functional and anatomic modality, is illustrated. In this chapter, the specific role of each modality is explained for each of the pillars of stagin
22#
發(fā)表于 2025-3-25 08:38:12 | 只看該作者
23#
發(fā)表于 2025-3-25 12:41:10 | 只看該作者
24#
發(fā)表于 2025-3-25 19:44:40 | 只看該作者
25#
發(fā)表于 2025-3-25 21:34:56 | 只看該作者
26#
發(fā)表于 2025-3-26 00:25:14 | 只看該作者
27#
發(fā)表于 2025-3-26 05:36:41 | 只看該作者
28#
發(fā)表于 2025-3-26 11:36:43 | 只看該作者
Systemic Treatment for Metastatic or Recurrent Disease,ismal, where the malignancy is refractory to conventional cytotoxic chemotherapy and associated with poor prognosis. While therapeutic advances over the past several years have resulted in improved patient outcomes, the observed benefits have been modest, highlighting the need for the identification
29#
發(fā)表于 2025-3-26 14:18:45 | 只看該作者
Immunotherapy in Esophageal Cancer,es has been shown to improve outcomes in a number of solid tumors, leading to their routine use in clinical practice. Early phase evaluation of immune checkpoint inhibitors demonstrated encouraging results in esophageal cancer, and studies in the chemorefractory setting have confirmed the activity o
30#
發(fā)表于 2025-3-26 20:32:06 | 只看該作者
Palliative Approaches in Esophageal Cancer,ophageal cancer remains a devastating disease in the world. Early diagnosis is difficult, since dysphagia, the common presentation symptom, occurs in late stage of the disease. When diagnosed, many patients miss the opportunity for surgical therapy. Also, patients with esophageal cancer are usually
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-15 15:29
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
浦县| 九龙县| 昌邑市| 左云县| 江口县| 沛县| 曲靖市| 应用必备| 龙岩市| 霍林郭勒市| 白山市| 吉木萨尔县| 长乐市| 娄底市| 渭南市| 百色市| 平舆县| 德州市| 鸡西市| 台东县| 哈巴河县| 施甸县| 洛宁县| 洪湖市| 永平县| 丰城市| 汨罗市| 余庆县| 安溪县| 锡林浩特市| 望都县| 会泽县| 襄汾县| 酒泉市| 漠河县| 淳安县| 兴山县| 襄城县| 高要市| 天柱县| 普格县|